Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 11 May 2001: Vol. 292. no. 5519, pp. 1160 - 1164 DOI: 10.1126/science.1059344
|
|
Reports
Structural Mechanism for Statin Inhibition of HMG-CoA Reductase
Eva S. Istvan,1
Johann Deisenhofer12*
HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase
(HMGR) catalyzes the committed step in cholesterol biosynthesis. Statins are HMGR inhibitors with inhibition constant values in the
nanomolar range that effectively lower serum cholesterol levels and are
widely prescribed in the treatment of hypercholesterolemia. We have
determined structures of the catalytic portion of human HMGR complexed
with six different statins. The statins occupy a portion of the binding
site of HMG-CoA, thus blocking access of this substrate to the active
site. Near the carboxyl terminus of HMGR, several catalytically
relevant residues are disordered in the enzyme-statin complexes. If
these residues were not flexible, they would sterically hinder statin
binding.
1 Department of Biochemistry,
2 Howard Hughes Medical Institute, University of
Texas Southwestern Medical Center at Dallas, TX 75390-9050, USA.
*
To whom correspondence should be addressed. E-mail:
Johann.Deisenhofer{at}UTSouthwestern.edu
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Regulation of leukemic cell differentiation and retinoid-induced gene expression by statins.
- A. Sassano, M. Lo Iacono, G. Antico, A. Jordan, S. Uddin, R. A. Calogero, and L. C. Platanias (2009)
Mol. Cancer Ther.
8, 615-625
| Abstract »
| Full Text »
| PDF »
- Interaction between statins and clopidogrel: is there anything clinically relevant?.
- R. Bhindi, O. Ormerod, J. Newton, A.P. Banning, and L. Testa (2008)
QJM
101, 915-925
| Abstract »
| Full Text »
| PDF »
- Alternative Splicing of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Is Associated With Plasma Low-Density Lipoprotein Cholesterol Response to Simvastatin.
- M. W. Medina, F. Gao, W. Ruan, J. I. Rotter, and R. M. Krauss (2008)
Circulation
118, 355-362
| Abstract »
| Full Text »
| PDF »
- Statin-Dependent Suppression of the Akt/Mammalian Target of Rapamycin Signaling Cascade and Programmed Cell Death 4 Up-Regulation in Renal Cell Carcinoma.
- J. Woodard, A. Sassano, N. Hay, and L. C. Platanias (2008)
Clin. Cancer Res.
14, 4640-4649
| Abstract »
| Full Text »
| PDF »
- Review: Statins and stroke.
- M. Rodriguez-Yanez, J. Agulla, R. Rodriguez-Gonzalez, T. Sobrino, and J. Castillo (2008)
Therapeutic Advances in Cardiovascular Disease
2, 157-166
| Abstract »
| PDF »
- Biphasic Regulation of HMG-CoA Reductase Expression and Activity during Wound Healing and Its Functional Role in the Control of Keratinocyte Angiogenic and Proliferative Responses.
- D. Schiefelbein, I. Goren, B. Fisslthaler, H. Schmidt, G. Geisslinger, J. Pfeilschifter, and S. Frank (2008)
J. Biol. Chem.
283, 15479-15490
| Abstract »
| Full Text »
| PDF »
- Variation in the 3-Hydroxyl-3-Methylglutaryl Coenzyme A Reductase Gene Is Associated With Racial Differences in Low-Density Lipoprotein Cholesterol Response to Simvastatin Treatment.
- R. M. Krauss, L. M. Mangravite, J. D. Smith, M. W. Medina, D. Wang, X. Guo, M. J. Rieder, J. A. Simon, S. B. Hulley, D. Waters, et al. (2008)
Circulation
117, 1537-1544
| Abstract »
| Full Text »
| PDF »
- The Guinea Pig as a Preclinical Model for Demonstrating the Efficacy and Safety of Statins.
- C. S. Madsen, E. Janovitz, R. Zhang, Van Nguyen-Tran, C. S. Ryan, X. Yin, H. Monshizadegan, M. Chang, C. D'Arienzo, S. Scheer, et al. (2008)
J. Pharmacol. Exp. Ther.
324, 576-586
| Abstract »
| Full Text »
| PDF »
- Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis.
- C. M. Shachaf, O. D. Perez, S. Youssef, A. C. Fan, S. Elchuri, M. J. Goldstein, A. E. Shirer, O. Sharpe, J. Chen, D. J. Mitchell, et al. (2007)
Blood
110, 2674-2684
| Abstract »
| Full Text »
| PDF »
- Apomine Enhances the Antitumor Effects of Lovastatin on Myeloma Cells by Down-Regulating 3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase.
- A. J. Roelofs, C. M. Edwards, R. G. G. Russell, F. H. Ebetino, M. J. Rogers, and P. A. Hulley (2007)
J. Pharmacol. Exp. Ther.
322, 228-235
| Abstract »
| Full Text »
| PDF »
- Suppressive Effects of Statins on Acute Promyelocytic Leukemia Cells.
- A. Sassano, E. Katsoulidis, G. Antico, J. K. Altman, A. J. Redig, S. Minucci, M. S. Tallman, and L. C. Platanias (2007)
Cancer Res.
67, 4524-4532
| Abstract »
| Full Text »
| PDF »
- Simvastatin Potentiates TNF-{alpha}-Induced Apoptosis through the Down-Regulation of NF-{kappa}B-Dependent Antiapoptotic Gene Products: Role of I{kappa}B{alpha} Kinase and TGF-beta-Activated Kinase-1.
- K. S. Ahn, G. Sethi, and B. B. Aggarwal (2007)
J. Immunol.
178, 2507-2516
| Abstract »
| Full Text »
| PDF »
- Discontinuation of Statin Treatment in Stroke Patients.
- M. Endres and U. Laufs (2006)
Stroke
37, 2640-2643
| Abstract »
| Full Text »
| PDF »
- Breast Cancer Growth Prevention by Statins..
- M. J. Campbell, L. J. Esserman, Y. Zhou, M. Shoemaker, M. Lobo, E. Borman, F. Baehner, A. S. Kumar, K. Adduci, C. Marx, et al. (2006)
Cancer Res.
66, 8707-8714
| Abstract »
| Full Text »
| PDF »
- Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells..
- U. Sivaprasad, T. Abbas, and A. Dutta (2006)
Mol. Cancer Ther.
5, 2310-2316
| Abstract »
| Full Text »
| PDF »
- Statins and Cancer Risk: A Meta-analysis.
- K. M. Dale, C. I. Coleman, N. N. Henyan, J. Kluger, and C. M. White (2006)
JAMA
295, 74-80
| Abstract »
| Full Text »
| PDF »
- An Inquiry into Protein Structure and Genetic Disease: Introducing Undergraduates to Bioinformatics in a Large Introductory Course.
- A. E. Bednarski, S. C.R. Elgin, and H. B. Pakrasi (2005)
CBE Life Sci Educ
4, 207-220
| Abstract »
| Full Text »
| PDF »
- Regulation of Macrophage Cholesterol Efflux through Hydroxymethylglutaryl-CoA Reductase Inhibition: A ROLE FOR RhoA IN ABCA1-MEDIATED CHOLESTEROL EFFLUX.
- C. A. Argmann, J. Y. Edwards, C. G. Sawyez, C. H. O'Neil, R. A. Hegele, J. G. Pickering, and M. W. Huff (2005)
J. Biol. Chem.
280, 22212-22221
| Abstract »
| Full Text »
| PDF »
- Efficacy and safety of rosuvastatin in treatment of dyslipidemia.
- J. M. McKenney (2005)
Am. J. Health Syst. Pharm.
62, 1033-1047
| Abstract »
| Full Text »
| PDF »
- Atorvastatin Induces T Cell Anergy via Phosphorylation of ERK1.
- S. Waiczies, T. Prozorovski, C. Infante-Duarte, A. Hahner, O. Aktas, O. Ullrich, and F. Zipp (2005)
J. Immunol.
174, 5630-5635
| Abstract »
| Full Text »
| PDF »
- Update on Statins: 2003.
- C. J. Vaughan and A. M. Gotto Jr (2004)
Circulation
110, 886-892
| Full Text »
| PDF »
- Non-high-density lipoprotein cholesterol as a risk factor: addressing risk associated with apolipoprotein B-containing lipoproteins.
- M.J Chapman and M Caslake (2004)
Eur. Heart J. Suppl.
6, A43-A48
| Abstract »
| Full Text »
| PDF »
- Inhibition of Adrenal Cortical Steroid Formation by Procaine Is Mediated by Reduction of the cAMP-Induced 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Messenger Ribonucleic Acid Levels.
- J. Xu, L. Lecanu, Z. Han, Z. Yao, J. Greeson, and V. Papadopoulos (2003)
J. Pharmacol. Exp. Ther.
307, 1148-1157
| Abstract »
| Full Text »
| PDF »
- Crystal Structure of a Statin Bound to a Class II Hydroxymethylglutaryl-CoA Reductase.
- L. Tabernero, V. W. Rodwell, and C. V. Stauffacher (2003)
J. Biol. Chem.
278, 19933-19938
| Abstract »
| Full Text »
| PDF »
- Human T Cell Receptor {gamma}{delta} Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells.
- H.-J. Gober, M. Kistowska, L. Angman, P. Jeno, L. Mori, and G. De Libero (2003)
J. Exp. Med.
197, 163-168
| Abstract »
| Full Text »
| PDF »
- Inferring functional constraints and divergence in protein families using 3D mapping of phylogenetic information.
- C. Blouin, Y. Boucher, and A. J. Roger (2003)
Nucleic Acids Res.
31, 790-797
| Abstract »
| Full Text »
| PDF »
|
|